Core Viewpoint - Firefly Aerospace Inc. is facing a class action lawsuit for alleged violations of federal securities laws, with claims that the company made false and misleading statements regarding its business operations and the demand for its products [1][3]. Summary by Sections Class Action Details - The class period for the lawsuit is defined as from August 7, 2025, to September 29, 2025, during which shareholders are encouraged to contact the DJS Law Group for potential lead plaintiff appointments [2]. - The lawsuit alleges that Firefly exaggerated the demand for its Spacecraft Solutions division and misled investors about the commercial potential of the Alpha rocket, resulting in materially misleading public statements throughout the class period [3]. Next Steps for Shareholders - Shareholders who purchased shares of Firefly during the specified timeframe can register to participate in the case, which includes enrollment in a portfolio monitoring software for status updates [4]. Legal Representation - DJS Law Group specializes in securities class actions and corporate governance litigation, focusing on enhancing investor returns through advocacy and legal support [5].

Nov 26, 2025 8:00 AM Eastern Standard Time Skye Bioscience, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights – SKYE Share LOS ANGELES--(BUSINESS WIRE)--The DJS Law Group reminds investors of a class action lawsuit against Skye Bioscience, Inc. ("Skye†or "the Company†) (NASDAQ: SKYE) for violations of §§10(b) and 20(a) of the Securities Exchange Act of 1934 and Rule 10b-5 promulgated thereunder by the U.S. Securities and Exchange Commission. Shareholders who purcha ...

NEW YORK, Nov. 24, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of James Hardie Industries plc. (NYSE: JHX). Shareholders who purchased shares of JHX during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/james-hardie-industries-plc-loss-submission-form/?id=178597&from=3 CLASS ...

New York, New York--(Newsfile Corp. - November 17, 2025) - Levi & Korsinsky notifies investors that it has commenced an investigation of Ardent Health, Inc. ("Ardent Health, Inc.") (NYSE: ARDT) concerning possible violations of federal securities laws.Ardent issued a press release on November 12, 2025, announcing its financial results for the third quarter of 2025. In connection with that release, the Company disclosed that it recorded a $43 million reduction in revenue due to a change in accounting estima ...

New York, New York--(Newsfile Corp. - November 17, 2025) - Levi & Korsinsky notifies investors that it has commenced an investigation of Bitdeer Technologies Group ("Bitdeer Technologies Group") (NASDAQ: BTDR) concerning possible violations of federal securities laws.Bitdeer issued a press release on November 10, 2025, reporting its unaudited financial results for the third quarter of 2025. Among other items, Bitdeer reported earnings per share of -$1.28, significantly missing the consensus estimate of -$0 ...

Core Insights - Fiserv, Inc. is a global provider of financial services technology, offering services such as payment processing, risk management, and data analytics, and is set to go public on NASDAQ [1] - The Schall Law Firm is investigating Fiserv for potential securities law violations related to misleading statements and undisclosed information following a disappointing third-quarter earnings report [2][6] - Fiserv's CEO acknowledged that previous forecasts were overly optimistic, leading to a 43% drop in stock price on the day of the earnings report [3][6] Financial Performance - Fiserv's stock is currently priced at $114.23, with fluctuations between a low of $112.54 and a high of $114.23 on the day [4] - Over the past year, the stock has reached a high of $188.85 and a low of $109.115, with a market capitalization of approximately $116.2 billion [4] - Today's trading volume for FISV is 20,051,164 shares, indicating significant investor interest amid ongoing challenges [5][6]

Company Overview - Beyond Meat, Inc. specializes in plant-based meat alternatives, including products like the Beyond Burger, and utilizes non-GMO ingredients [3]. Allegations and Financial Impact - On October 24, 2025, Beyond Meat announced a significant non-cash impairment charge on certain assets, which led to a stock price drop of over 23% [4]. - Following the announcement, the company delayed its third-quarter earnings release on November 3, 2025, resulting in an additional decline of 16.52% in its share price [4]. Legal Investigation - Edelson Lechtzin LLP is investigating potential violations of federal securities laws related to Beyond Meat, stemming from allegations of providing misleading business information to investors [1].

Core Insights - Stride, Inc. is under investigation for possible violations of federal securities laws following disappointing enrollment numbers and guidance despite beating earnings expectations [1][2] - The company's stock price dropped significantly after the earnings report, indicating market reaction to the negative outlook [3] Financial Performance - Stride reported its first quarter fiscal 2026 earnings on October 28, 2025, with earnings exceeding expectations [2] - However, enrollment numbers and forward-looking guidance were significantly below market expectations, leading to concerns about the company's future performance [2] Market Reaction - Following the earnings report, Stride's stock price fell by $68.51 per share, opening at $85.02 per share [3]

NEW YORK, Nov. 10, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of DexCom, Inc. (NASDAQ: DXCM). Shareholders who purchased shares of DXCM during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery. CONTACT US HERE: https://securitiesclasslaw.com/securities/dexcom-inc-loss-submission-form-2/?id=176107&from=3 CLASS PERIOD: July 26, 2024 to Se ...

Core Viewpoint - Faruqi & Faruqi, LLP is investigating potential securities law violations at Baxter International Inc. following serious safety concerns related to its Novum IQ Large Volume Pump, which has led to significant investor losses and stock price decline [2][3][5]. Group 1: Safety Concerns and Legal Investigation - A Missouri news outlet reported serious safety issues with Baxter's Novum IQ Large Volume Pump, citing a whistleblower who claimed the pumps were unsafe for patient treatment [3]. - Baxter acknowledged potential under infusion risks in warning letters to customers, disclosing one serious injury linked to the device [4]. - The FDA classified the situation as a Class I recall, indicating a severe risk of serious injury or death, with Baxter reporting 79 serious injury cases and two patient deaths associated with the device [4]. Group 2: Stock Price Impact - Following the announcement of a voluntary and temporary pause in shipments and installations of the Novum LVP, Baxter's stock price fell by $6.24 per share, or 22.4%, closing at $21.61 per share on July 31, 2025 [5].